-
September 13, 2011PREVIEW
Treatment with the experimental drug lebrikizumab, a humanized monoclonal antibody to interleukin-13, increased lung function in adults with asthma. Drug effects in the Phase II trial were...
-
June 14, 2011PREVIEW
In patients with asthma, leukotriene-receptor antagonists (LTRAs) managed the disease just as successfully as inhaled glucocorticoid for first-line therapy or long-acting beta-2 agonist as add-...
-
April 1, 2011PREVIEW
Adding omalizumab (Xolair—Genentech/Novartis) to guideline-based therapy reduced asthma symptoms and use of inhaled corticosteroids and nearly eliminated seasonal increases in asthma...
-
February 1, 2011PREVIEW
A single 15-μg dose of inactivated influenza A (H1N1) vaccine is safe and induces a strong immunogenic response in most patients with asthma, according to a study recently published in the ...
-
August 26, 2010PREVIEW
In a small, randomized, double-blind, placebo-controlled trial of children with asthma, montelukast (Singulair—Merck), a leukotriene receptor antagonist, reduced efficacy of allergen-...
Pages
